Elevance Health Inc (ELV)
Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell
$384.01
Buy
$400.50
$1.77 (+0.45%)
Prices updated at 04 Mar 2025, 13:31 EST
| Prices minimum 15 mins delay
Prices in USD
Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets. Its business segments are Commercial and Specialty Business, Government Business and Other.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
---|---|---|
171,340m | 176,810m | |
- | - | |
- | - | |
- | - | |
5,987m | 5,980m | |
- | - | |
Sales, General and administrative | - | - |
Interest expenses | 1,030m | 1,185m |
Provision for income taxes | 1,724m | 1,933m |
Operating expenses | - | - |
Income before taxes | 7,715m | 7,904m |
Net income available to common shareholders | 5,987m | 5,980m |
25.38 | 25.81 | |
Net interest income | -1,030m | -1,185m |
Advertising and promotion | - | - |
Net investment income, net | 420m | 472m |
Realised capital gains (losses), net | - | - |
Total benefits, claims and expenses | - | - |
Earnings per share (diluted) | 25.22 | 25.68 |
Free cash flow per share | 34.5274 | 3.7206 |
Book value/share | 164.8553 | 192.4348 |
Debt equity ratio | 0.591411 | 0.707201 |
Balance sheet
Year | 2023 | 2024 |
---|---|---|
Current assets | - | - |
Current liabilities | - | - |
Total capital | 62,552m | 70,533m |
Total debt | 25,120m | 31,232m |
Total equity | 39,306m | 41,315m |
Total non current liabilities | - | - |
Loans | 23,246m | 29,218m |
Total assets | 108,928m | 116,889m |
Total liabilities | - | - |
Cash and cash equivalents | 6,526m | 8,288m |
Common stock | 233m | 227m |
Cash flow
Year | 2023 | 2024 |
---|---|---|
Cash at beginning of period | 7,387m | 6,526m |
Cash dividends paid | -1,395m | -1,508m |
6,765m | 4,552m | |
Investments (gains) losses | -5,572m | -5,167m |
6,526m | 8,288m | |
Net income | - | - |
8,061m | 5,808m | |
-1,296m | -1,256m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.